top of page
  • Writer's pictureNicholas Murtha

LSRHD member to attend the E.U. Clinical Residency Fellowship of the Université Paris-Saclay

Updated: Feb 22, 2022


Liver Surgery Research HD


PRESS RELEASE


FOR IMMEDIATE RELEASE


LSRHD member to attend the E.U. Clinical Residency Fellowship of the Université Paris-Saclay


Oct. 3, 2021


HEIDELBERG, GERMANY – Dr. med. Juri Fuchs, a highly valued member of Liver Surgery Research HD’s research team, accepted an invitation to participate in the E.U. Clinical Residency Fellowship of the Université Paris-Saclay. This 6-month fellowship will take place at the Center for Pediatric Liver Transplantation and Hepatobiliary Surgery, Hôpital Bicêtre, Assistance Publique - Hôpitaux de Paris, Université Paris-Saclay and will focus on clinical training in pediatric liver transplantation and hepatobiliary surgery and research in the field of rare liver diseases in children.

Dr. med. Juri Fuchs surgery resident and liver surgery researcher at Heidelberg University Surgery Clinic, Germany. (Heidelberg University Photo)


Cancer is at the heart of the public health service mission of the Assistance Publique - Hôpitaux de Paris (AP-HP), with over one-third of all cancer patients in France being treated at AP-HP hospitals. AP-HP treats all cancers, at all stages, covering all ages of the population. This includes rare cancers that affect less than 6 people out of 100,000 people per year, in addition to childhood cancer, rare diseases that account for 1% of cancers. In 2018, 61,844 patients, including 38,975 new patients, were treated at AP-HP for cancer. To learn more, visit https://www.aphp.fr/pass-sanitaire-lhopital.


Though his absence will impact the research abilities of the LSRHD team, this fellowship will provide Dr. Fuchs with advanced training and first-hand experience in a highly specialized field of pediatric liver transplantation and hepatobiliary surgery in one of Europe's largest centers specializing in this area of medical care and treatment. This will positively impact Dr. Fuchs’ expertise and bring value to the LSRHD research team and the University of Heidelberg Surgery Clinic.


About Liver Surgery Research HD


Liver Surgery Research HD (LSRHD) is a research group located at Heidelberg University specializing in liver regeneration after hepatectomy (liver resection) and post-hepatectomy liver failure, HCC development and treatment (especially in the context of MAFLD [metabolically associated fatty liver disease]), and rare liver lesions and diseases. LSRHD is currently working on over 24 research projects, has 4 articles under publication review, has 1 article accepted for publication, and over 100 published authorships. LSRHD is also the founder of the RELIVE (RarE LIVEr) Initiative, a multidisciplinary project to establish evidence-based therapies for rare liver diseases. To learn more, visit www.liversurgeryresearch.com.


Contact


Nicholas Murtha

Public Relations, Communications, and Marketing Specialist

Liver Surgery Research HD

liversurgeryresearch@protonmail.com

nicholas.murtha@protonmail.com


###


32 views0 comments

Recent Posts

See All
Post: Blog2_Post
bottom of page